Advancing Infectious Disease Detection and Response in Viet Nam

推进越南传染病检测和应对

• 批准号: 10001407
• 负责人: Tan Dang
• 金额: --
• 依托单位: GENERAL DEPARTMENT/ PREVENTIVE MEDICINE
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-30 至 2024-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10001407
• 关键词: Advancing; Infectious; Disease; Detection; Response

PROJECT SUMMARY FOR APPLICATION Since 1998, the General Department of Preventive Medicine (GDPM) and the United States Centers for Disease Control and Prevention (U.S. CDC) have worked closely to strengthen the surveillance capacity in Viet Nam in emerging infectious disease prevention and response, including preparedness for pandemic influenza. In recent years, the GDPM is the focal point for the Viet Nam Ministry of Health to collaborate with other Ministries in Viet Nam, as well as with international agencies as the national focal point for implementation of International Health Regulations and the Global Health Security Agenda. In 2018, with support from the U.S. CDC, the GDPM has implemented Event Based Surveillance (EBS) and has conducted a nationwide survey on the sero-prevalence of hepatitis B and C. The GDPM would like to propose a Project Application for 5 years. The total funding requested for the first year is USD 504,295 with two research proposals that will expand upon EBS implementation and the nationwide survey on sero-prevalence of hepatitis B and C. The first research study on EBS proposes a mixed methods approach to evaluate different implementation interventions (above routine implementation) in order to improve the frequency, timeliness and quality of the reported events. The second research study proposal focuses on identifying the molecular epidemiology of blood-borne Hepatitis viruses in Viet Nam. The research proposals within this application will be coordinated by the GDPM, a specialized department of the Viet Nam Ministry of Health which performs the function of advising and assisting the Minster of Health in exercising State management, and organizing the implementation of law provisions on preventive medicine nationwide. In this capacity, GDPM is pursuing a Project Application with the U.S. CDC that will support this research to: 1) Use lessons learned from the EBS mixed methods evaluation interventions to improve EBS implementation in Viet Nam; and 2) Provide the necessary database for policy making and action plan development on viral hepatitis prevention and control, as well as diagnosis and management of patients in curative facilities. The research will propose a mixed-methods approach EBS evaluation that will be used to assess the effectiveness and impact of the implementation interventions, and to conduct genotyping of HBV and HCV in a subset of specimens to describe the distribution of their genotypes. We will retrospectively collect costs incurred by any organization involved and essential to the rollout.

申请项目摘要 自1998年以来，预防医学总部（GRESS）和美国预防医学中心 美国疾病控制和预防中心（CDC）密切合作，加强监测能力， 越南在预防和应对新出现的传染病，包括防备大流行方面的作用 流感。近年来，该委员会是越南卫生部合作的协调中心， 与越南其他部委以及作为国家协调中心的国际机构合作， 执行《国际卫生条例》和《全球卫生安全议程》。2018年随着 在美国疾病控制和预防中心的支持下，该中心实施了基于事件的监测（EBS），并进行了 全国性的B型和C型肝炎血清流行率调查。 该公司希望提出一个为期5年的项目申请。第一个项目所需资金总额 一年是504，295美元，有两个研究提案，将扩大EBS的实施和 全国B肝炎和丙型肝炎血清流行率调查。关于EBS的第一项研究提出了一个 评价不同执行干预措施的混合方法（高于常规方法） 执行情况），以提高报告活动的频率、及时性和质量。的 第二项研究建议的重点是确定血液传播的分子流行病学 越南的肝炎病毒 本申请中的研究建议将由专门的部门GIGENCE协调 越南卫生部执行向越南卫生部敏斯特部长提供咨询和协助的职能， 卫生实行国家管理，组织实施卫生法 全国预防医学。在这个职位上，甘精胰岛素正在寻求与美国的项目申请。 CDC将支持这项研究：1）使用从EBS混合方法评估中吸取的经验教训 改善越南EBS实施的干预措施;以及2）提供必要的数据库， 制定关于病毒性肝炎预防和控制以及诊断的政策和行动计划 和治疗设施中病人的管理。 该研究将提出一种混合方法的方法EBS评估，将用于评估 实施干预措施的有效性和影响，并对HBV和HCV进行基因分型 在样本的子集中描述其基因型的分布。我们将回顾性地收集 任何相关组织产生的成本，以及对推出至关重要的成本。